Korean J Parasitol.  1999 Dec;37(4):289-292. 10.3347/kjp.1999.37.4.289.

Towards developing a diagnostic regimen for the treatment follow-up of Trypanosoma brucei gambiense

Affiliations
  • 1University of the North, Parasitology Research Program, Phuthaditjaba, South Africa. mbati@uniqwa.ac.za

Abstract

BALB/c mice infected with a high virulent strain of Trypanosoma brucei gambiense IL3707 were treated intraperitoneally (ip) with either Melarsoprol (Mel-B) or PSG(+) buffer as controls. The mice were subsequently monitored regularly for parasites by direct microscopic examination of their tail blood or buffy coat and by polymerase chain reaction (PCR). Mel-B was found to be an effective drug for treatment against T.b. gambiense because at the end of the first treatment schedule, all treated mice were negative for parasites even by PCR, while all the control animals were positive. Three of the five Mel-B treated mice, while parasitologically negative, were PCR positive between 53 and 80 days post infection (DPI), indicating that they still harbored an infection. All treated mice were subsequently negative for parasites even by PCR at 88 DPI. A combination of conventional microscopic examination and PCR offers a good prediction of cure following treatment of trypanosomosis.

Keyword

Trypanosoma brucei gambiense; mice; Mel-B; treatment follow-up; diagnosis; PCR

MeSH Terms

Animal
Follow-Up Studies
Melarsoprol/therapeutic use*
Mice
Mice, Inbred BALB C
Polymerase Chain Reaction
Trypanocidal Agents/therapeutic use*
Trypanosoma brucei gambiense*/genetics
Trypanosomiasis, African/drug therapy*
Trypanosomiasis, African/diagnosis
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr